University Cancer Research Fund Enables Innovative Solutions to Complex Problems
Researchers investigating a genetic mutation in brain cancer and leukemia patients have discovered how one cancer metabolite battles another normal metabolite to contribute cancer development. Helping the “good guys” win that battle could yield new approaches for treatment.
Heartfelt thanks to the staff of the N.C. Cancer Hospital, fellow UNC employees, our volunteers, patients, families, and friends. The Oncology Winter Coat Drive was a tremendous success - 107 winter coats were collected and distributed to our families and their caregivers throughout the month of January until February 11, 2011. Hats, scarves, gloves, and socks were added to each winter coat selection as needed. A very special Valentine’s Day thank you to all for sharing your hearts!
C. elegans model shows how RAS oncogene switching determines a cell's fate
Kaposi sarcoma-associated herpesvirus produces a protein that blocks the cell's inflammatory response
Donald L. Rosenstein joins UNC Lineberger Comprehensive Cancer Center to lead new cancer support program
Chapel Hill, NC - Donald L. Rosenstein, MD, joins the University of North Carolina's Lineberger Comprehensive Cancer Center as Director of the new UNC Comprehensive Cancer Support Program.
UNC study: New genomic test may guide breast cancer treatment choices
Dr. Kimberly Kasow joins UNC School of Medicine Department of Pediatrics to lead pediatric bone marrow transplantation program
Chapel Hill, NC - Kimberly Kasow, DO, has joined the University of North Carolina at Chapel Hill as director of the UNC Pediatric Bone Marrow Transplantation program. Kasow is an associate professor of pediatrics and a member of the UNC Lineberger Comprehensive Cancer Center.
CHAPEL HILL –Dr. Shelley Earp, UNC Lineberger director, was invited to address the NC Senate Science and Technology Committee to talk about UNC and the Lineberger Comprehensive Cancer Center as the state’s Center of Excellence in Cancer Research.
Members of the NC General Assembly are touring the North Carolina Cancer Hospital to get an early view of the state’s new state-of-the-art facility. Greeted by UNC-Chapel Hill Chancellor Holden Thorp and UNC School of Medicine Dean Bill Roper, the legislators visited several key locales in the building that will improve the way cancer care is delivered at UNC and across North Carolina
Chapel Hill, NC - Hyman B. Muss, MD, has joined the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill School of Medicine. Muss will be a professor of medicine and will develop and lead a new program in geriatric oncology.
Chapel Hill, NC - A disagreement between Nancy Allbritton, MD, PhD and David Lawrence, PhD over which cancer - breast or prostate - should be the higher priority in their partnership resulted in two successful NIH grant proposals. Lawrence is taking the lead on a prostate cancer grant while Allbritton leads a breast cancer grant – totaling almost $5 million over the next five years.
In a study published this month in the Journal of Clinical Oncology, the results of a clinical trial of the drug bevacizumab to treat colon cancer in combination with the standard therapy found that the drug did not significantly increase disease-free survival in patients with stage II and stage III colon cancer.
G-Zero Therapeutics funded under Qualifying Therapeutic Discovery Project
Study from The Cancer Genome Atlas an important step towards personalized therapy
Join the National Marrow Donor Program’s registry and you could save a life!
This profile is part of a series highlighting how UNC Lineberger and the UNC School of Medicine are shaping the next generation of cancer researchers and physicians
QUANTEC review replaces 20-year old guidelines
Findings have potential for cancer, other age-related diseases
Findings may illuminate how cancer forms and migrates